FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22735111000001101: Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Aug 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
75109401000001117 Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
75109501000001118 Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Is a Ondansetron 8mg orodispersible films sugar free true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has dispensed dose form Conventional release orodispersible film true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Is a Setofilm true Inferred relationship Existential restriction modifier
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Has manufactured dose form Conventional release orodispersible film true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) 10 film Has AMP True Setofilm 8mg orodispersible films (Norgine Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start